Myriad Genetics Inc (NASDAQ:MYGN)
| 23.42 Delayed Data As of Jun 02 |  +0.32 / +1.39%Today’s Change | 13.92 Today|||52-Week Range 28.18 | +61.41% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 200.9M | 202.3M | 216.8M | 216.6M | |
| Cost of Goods Sold | 30.6M | 31.4M | 40.2M | 36.3M | ||
| Depreciation And Amortization | 15.1M | 18.3M | 18.0M | 18.3M | ||
| Operating Expenses | Gross Income | 155.2M | 152.6M | 158.6M | 162.0M | |
| General Expenses | 139.1M | 151.0M | 147.6M | 151.9M | ||
| Research And Development | 17.7M | 21.1M | 21.8M | 21.4M | ||
| Total Operating Expenses | 184.8M | 200.7M | 205.8M | 206.5M | ||
| Non-Operating Expenses | Operating Income | 16.1M | 1.6M | 11.0M | 10.1M | |
| Extraordinary Charge | -200.0K | -400.0K | -4.9M | -4.2M | ||
| Interest Expense On Debt | 1.1M | 2.2M | 3.4M | 3.2M | ||
| Other Expenses | 800.0K | 1.1M | 0.00 | -100.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 16.1M | 800.0K | 3.6M | 3.3M | |
| Income Taxes | -3.0M | -1.6M | -1.0M | -3.6M | ||
| Minority Interest | 0.00 | -100.0K | 0.00 | 0.00 | ||
| Net Income | 13.1M | -700.0K | 2.6M | 6.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 70.1M | 73.0M | 74.2M | 73.3M | |
| Shares To Calculate EPS Diluted | 72.9M | 73.0M | 76.5M | 74.9M | ||
| Earnings Per Share | EPS | $0.18 | -$0.01 | $0.03 | $0.09 | |
| EPS Diluted | $0.18 | -$0.01 | $0.03 | $0.09 | ||
